ZEB1 and breast carcinoma: In addition, in both prostate and breast cancers, miR-205 revealed to be capable to enhance radiation response by targeting ZEB1, a well-established EMT inhibitor [14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39].